Answers are grounded in this paper and cite their sources.
Study demonstrates potent JAK2 inhibition in cervical cancer using molecular dynamics and hydrogen bonding, highlighting a new strategy for therapy.
meeting drug-likeness criteria and displaying potent nanomolar JAK2 inhibition. Finally, 1-μs molecular dynamics simulations revealed that hydrophobic contacts and hydrogen bonding cooperatively stabilize these inhibitors within the JAK2 ATP-binding pocket. Collectively, these findings establish a QSAR-ML-guided strategy for accelerating JAK2 inhibitor discovery and highlight naphthalene-based scaffolds as promising leads for targeted cervical cancer therapy.
No takes yet. Share an insight, caveat, or question.
Todsaporn et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: